New research shows the pros and the cons of smart devices. From steps and calories to heartbeats and ZZ’s, your smart watch ...

Founded in 2014, Sim&Cure is French digital start-up focused on improving neurovascular treatments of cerebral aneurysm with a proprietary software suite. The Sim&Size™ software is a Class II medical ...

Merit predicts the portfolio, which includes devices used in procedures to remove or replace heart rhythm device leads, will add $40 million a year to its sales.

Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.

Merit Medical Systems (Nasdaq:MMSI) announced today that it agreed to acquire Cook Medical's lead management portfolio for ...

Growing Portfolio of Patents Further Advances the Company’s Mission to Develop Fully Implanted Devices for Those Suffering from Significant ...

Nimbl is the next generation of the Company’s basic lymphedema compression solution and is indicated for the treatment of lymphedema, chronic edema, venous insufficiency, and wound healing. The device ...

Implanting a pouch of stem-cell-derived pancreas cells under the skin of type 1 diabetics has enabled them to live without ...

Abstract: A urine collection system includes a urine collection device configured to collect urine discharged from a user and ...

A team of scientists from Massachusetts Institute of Technology (MIT), Brigham and Women’s Hospital, Harvard Medical School ...

Israel-based medtech startup Discure has secured $16m in Series A financing to advance its implantable device for treating ...